Показати простий запис статті
dc.contributor.author |
Yenamandra, S.P. |
|
dc.contributor.author |
Klein, G. |
|
dc.contributor.author |
Kashuba, E. |
|
dc.date.accessioned |
2018-06-15T14:00:35Z |
|
dc.date.available |
2018-06-15T14:00:35Z |
|
dc.date.issued |
2009 |
|
dc.identifier.citation |
Nuclear receptors and their role in epstein — barr virus induced b cell transformation / S.P. Yenamandra, G. Klein, E. Kashuba // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 67-73. — Бібліогр.: 81 назв. — англ. |
uk_UA |
dc.identifier.issn |
1812-9269 |
|
dc.identifier.uri |
http://dspace.nbuv.gov.ua/handle/123456789/135697 |
|
dc.description.abstract |
Epstein — Barr virus (EBV) is a lymphotropic virus that infects more than 90% of the human population, and targets B cells for
infection. Infection of human B cells leads to the malignant transformation and eventual immortalization. In latency III infection
six EBV-encoded nuclear antigens (EBNAs) and three latent membrane proteins (LMPs) are expressed in the transformed cells
that can grow as a lymphoblastoid cell lines in vitro. These proteins hijack the normal B cell growth pathways by activating the
constitutive growth promotion and external survival signals. We have determined a set of the nuclear receptors that are up- (and
down-) regulated in the latency III infected cells at the mRNA level. In the present paper we discussed the possible role of these
receptors in B cell transformation upon EBV infection based on the literature data. |
uk_UA |
dc.language.iso |
en |
uk_UA |
dc.publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
uk_UA |
dc.relation.ispartof |
Experimental Oncology |
|
dc.subject |
Reviews |
uk_UA |
dc.title |
Nuclear receptors and their role in epstein — barr virus induced b cell transformation |
uk_UA |
dc.type |
Article |
uk_UA |
dc.status |
published earlier |
uk_UA |
Файли у цій статті
Ця стаття з'являється у наступних колекціях
Показати простий запис статті